CVS 2027 Scientific Program

Title: The promising future of the unique translational tool to manage cardiac self-renewal and regeneration via engineered resident cardiac stem cells

Cell-based therapy holds great potential to address unmet medical needs and revolutionize the healthcare bioindustry, as demonstrated by CAR-T cell therapy and stem cell transplantation, and has been considered as a promising option in the treatment of ischemic heart disease. The [....] » Read More